Protein arginine methylation has been recently identified as an important form of post-translational modification (PTM). It is carried out by the protein arginine methyltransferase (PRMT) family of enzymes, which in mammals consists of nine members. Among them, PRMT1 is the major arginine methyltransferase and participates in transcription, signal transduction, development and cancer. The function of PRMT1 in craniofacial development remains unclear. We generated Wnt1-Cre;Prmt1 fl/fl mice with cranial neural crest (CNC)-specific deletion of
Introduction
Protein arginine methylation is an important form of post-translational modification (PTM). It is carried out by the nine members of the protein arginine methyltransferases (PRMT) family identified so far in mammals (Bedford and Clarke, 2009 ). These enzymes fall into three categories: Type I (PRMT1, PRMT2, PRMT3, PRMT4, PRMT6, and PRMT8), type II (PRMT5 and PRMT9) and type III (PRMT7) (Feng et al., 2013; Yang et al., 2014) . Type I enzymes carry out the formation of mono-methylarginine (MMA) as an intermediate before progressing to the formation of asymmetric di-methylarginine (aDMA). Type II enzymes carry out the formation of MMA and symmetric di-methylarginine (sDMA). The Type III enzyme only forms MMA. PRMT1 is the major PRMT, responsible for > 85% of all arginine methylation activity in mammalian cells (Tang et al., 2000) . PRMT1 is known to methylate a number of protein substrates including histone H4 and non-histone proteins (Guo et al., 2014) , and subsequently regulates a range of cellular processes, including RNA processing, gene transcription, DNA damage repair, signal transduction and protein translocation (Bedford and Clarke, 2009) . PRMT1 is further shown to modulate the development of the central nervous system (Hashimoto et al., 2016) , skeletal muscle regeneration (Blanc et al., 2017) , and cancer progression (Avasarala et al., 2015 , Thandapani et al., 2015 .
Craniofacial development is regulated by a coordinated spatiotemporal network of gene expression, which gives rise to stereotypic pattern formation (Gou et al., 2015) . The study of craniofacial bone development is essential for understanding a large number of clinical syndromes that impact the face and skull, and for the development of new therapeutic strategies for craniofacial defects. Novel transgenic mouse models with craniofacial malformations have revealed new insights into the genetic regulation of craniofacial development. However, most studies have conducted two-dimensional (2D) analyses of tissues or sections and molecular changes in different signaling pathways. The skull is morphologically, evolutionarily, and developmentally complex; therefore 2D analysis is not sufficient to paint a comprehensive picture of changes in mutant embryos. Now that threedimensional (3D) volumetric imaging has been adapted for customdesigned analysis and viewing, many researchers apply micro-
